Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Cytori Therapeutics Inc    CYTX

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2016 9,33 M
EBIT 2016 -20,3 M
Net income 2016 -22,0 M
Debt 2016 -
Yield 2016 -
Sales 2017 11,8 M
EBIT 2017 -17,7 M
Net income 2017 -18,3 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales2016 3,49x
Capi. / Sales2017 2,75x
Capitalization 32,6 M
More Financials
Company
Cytori Therapeutics, Inc. is a late stage cell therapy company.Its develops autologous cell therapies from adipose tissue, using its proprietary technology, to treat a variety of medical conditions.Data from preclinical studies and clinical trials suggest that Cytori Cell Therapy acts principally... 
More about the company
Surperformance© ratings of Cytori Therapeutics Inc
Trading Rating : Investor Rating :
More Ratings
Latest news on CYTORI THERAPEUTICS INC
01/11 CYTORI THERAPEUTICS, INC. (NASDAQ : CYTX) Files An 8-K Regulation FD Disclosure
01/10 CYTORI THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and E..
01/10 Cytori to Expand Scleroderma Focus to Broader Hand Therapy Franchise Under th..
01/07 CYTORI THERAPEUTICS : to Provide Corporate Update at 2017 Biotech Showcase
01/06 Cytori Therapeutics to Provide Corporate Update at 2017 Biotech Showcase&trad..
01/05 NETWORKNEWSBREAKS – CYTORI (NA : CYTX) Continues to Advance Cytori Cell Th..
01/03 CYTORI THERAPEUTICS INC : Blog Coverage Cytori Announced Stock Purchase Agreemen..
2016 CYTORI THERAPEUTICS : Announces Common Stock Purchase Agreement with Institution..
2016 CYTORI THERAPEUTICS, INC. (NASDAQ : CYTX) Files An 8-K Entry into a Material Def..
2016 CYTORI THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Unregist..
More news
Sector news : Medical Equipment, Supplies & Distribution - NEC
08:49aDJLUXOTTICA FOUNDER : A Lifetime of Deals -- WSJ
08:49aDJLUXOTTICA : Merger to Create Eyewear Giant -- WSJ
08:48aDJWHAT'S NEWS : Business & Finance -- WSJ
01/16 ESSILOR INTL : Luxottica's merger helps Del Vecchio manage family risks
01/16DJLUXOTTICA : Another Big Splash by Italy's Eyewear King
More sector news : Medical Equipment, Supplies & Distribution - NEC
News from SeekingAlpha
2016 Cytori Therapeutics' (CYTX) CEO Marc Hedrick on Q1 2016 Results - Earnings Ca..
2016 Cytori Therapeutics EPS in-line, beats on revenue
2016 Cytori Cell Therapy an Orphan Drug in Europe for scleroderma-related hand dys..
2016 Notable earnings after Tuesday?s close
2016 Cytori's late-stage study of ECCS-50 in scleroderma 50% enrolled; study to co..
Advertisement
Chart CYTORI THERAPEUTICS INC
Duration : Period :
Cytori Therapeutics Inc Technical Analysis Chart | CYTX | US23283K1051 | 4-Traders
Full-screen chart
Income Statement Evolution
More Financials
Consensus 
Mean consensus OUTPERFORM
Number of Analysts 3
Average target price 5,25 $
Spread / Average Target 232%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Marc H. Hedrick President, Chief Executive Officer & Director
David M. Rickey Chairman
Tiago Girão CFO, Vice President & Head-Investor Relations
John K. Fraser Chief Scientist
Mark T. Marino Chief Medical Officer & Senior Vice President
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
CYTORI THERAPEUTICS IN..-4.14%33
MEDTRONIC PLC5.42%103 102
BAXTER INTERNATIONAL I..4.76%25 265
ZIMMER BIOMET HOLDINGS..11.63%23 075
C R BARD INC4.23%17 218
HOYA CORPORATION-2.11%16 568
More Results